Similar articles

• [Cytotoxicity of hydroxycamptothecin and four other antineoplastic agents on KB cells].

  Wang XW, Yu WJ, Shen ZM, Yang JL, Xu B. Wang XW, et al. Zhongguo Yao Li Xue Bao. 1987 Jan;8(1):86-90. Zhongguo Yao Li Xue Bao. 1987. PMID: 2955666 Chinese. No abstract available.
• Topoisomerase-I inhibitor SN-38 can induce DNA damage and chromosomal aberrations independent from DNA synthesis.

  Voigt W, Matsui S, Yin MB, Burhans WC, Minderman H, Rustum YM. Voigt W, et al. Anticancer Res. 1998 Sep-Oct;18(5A):3499-505. Anticancer Res. 1998. PMID: 9858931
• Camptothecin and minor-groove binder hybrid molecules: synthesis, inhibition of topoisomerase I, and anticancer cytotoxicity in vitro.

  Zhao R, al-Said NH, Sternbach DL, Lown JW. Zhao R, et al. J Med Chem. 1997 Jan 17;40(2):216-25. doi: 10.1021/jm9605804. J Med Chem. 1997. PMID: 9003520
• Mechanisms of topoisomerase I inhibition by anticancer drugs.

  Pommier Y, Tanizawa A, Kohn KW. Pommier Y, et al. Adv Pharmacol. 1994;29B:73-92. doi: 10.1016/s1054-3589(08)61132-1. Adv Pharmacol. 1994. PMID: 8996602 Review. No abstract available.
• [Current status of camptothecin derivatives as natural antitumor agents].

  Pan XD, Wang CY. Pan XD, et al. Yao Xue Xue Bao. 2003 Sep;38(9):715-20. Yao Xue Xue Bao. 2003. PMID: 14730926 Review. Chinese. No abstract available.